Skip To Main Content
Arthur Sun Myint on Muck Rack

Arthur Sun Myint

As seen in: British Journal of Cancer, Color Research & Application, Wiley, Wiley Online Library, Frontiers, MDPI, EJSO - European Journal of Surgical Oncology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Arthur Sun

Contact Arthur Sun, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Long-term Outcomes of Patients Treated with Contact X-ray Brachytherapy and external beam (chemo)radiotherapy Following Local Excision of rectal adenocarcinoma

|
By BioSciences Building, Crown Street, Mount Street, D Mark Pritchard, Muneeb Ul Haq, David Hughes, Muhammad Ahsan Javed, Humaira Yasmin, Carrie A. Duckworth, Shakil Ahmed, Arthur Sun Myint, Rajaram Sripadam
| EJSO - European Journal of Surgical Oncology Verified
KEYWORDS Rectal cancer radiotherapy chemotherapy local excision ‘watch and wait’ Get full text access Log in, subscribe or purchase for full access. REFERENCES 1. Pinheiro, M. ∙ Moreira, D.N. ∙ Ghidini, M. Colon and rectal cancer: An emergent public health problem World journal of gastroenterology : WJG. 2024; 30:644-651 2. Glynne-Jones, R. ∙ Wyrwicz, L. ∙ Tiret, E. ... Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Annals of oncology. 2018; 29:iv263-iv 3.
Open in Who Shared Issue with article?

Long-Term Outcomes of Patients with Poor Prognostic Factors Following Transanal Endoscopic Microsurgery (TEMS) for Early Rectal Cancer

|
By Muneeb Ul Haq, David Pritchard Verified, Arthur Sun Myint, Khaled Noureldin
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Metformin is a metabolic modulator and radiosensitiser in rectal cancer

|
By Arthur Sun Myint, Nadia Jacobo-Herrera, Joji Kitayama
| Frontiers
1 Introduction Colorectal cancer (CRC) has the 3rd highest incidence rate of cancer worldwide, and accounts for the 2nd highest cancer mortality rate (1). An estimated one in three cases of CRC occur in the lower bowel, or the rectum, the incidence of which are predicted to rise exponentially in the coming years (2).
Open in Who Shared Issue with article?
See all 14 articles